Early first-trimester maternal serum placental growth factor in trisomy 21 pregnancies

Ultrasound in Obstetrics and Gynecology

Volumn 37, Issue 5, 2011, Pages 515-519

  Cowans, N J ^a   Stamatopoulou, A ^a   Torring N ^b   Spencer, K ^a  

^a KING GEORGE HOSPITAL   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

aneuploidy; first trimester; PlGF; prenatal screening; trisomy

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD; DENMARK; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MASS SCREENING; MATERNAL AGE; METABOLISM; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; RETROSPECTIVE STUDY;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DENMARK; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RETROSPECTIVE STUDIES;

EID: 79955470573     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.8890     Document Type: Article

References (22)

1. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH,. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003; 110: 281-286. (Pubitemid 36298912)
2. Hauser S, Weich HA,. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 1993; 9: 259-268. (Pubitemid 24034347)
3. Maglione D, Guerriero V, Viglietto G, li-Bovi P, Persico MG,. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991; 88: 9267-9271. (Pubitemid 21915612)
4. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS,. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997; 18: 657-665. (Pubitemid 27448423)
5. Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K, Halmesmäki E,. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997; 56: 489-494. (Pubitemid 27081593)
6. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH,. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008; 32: 732-739.
7. Cowans NJ, Stamatopoulou A, Matwejew E, von Kaisenberg CS, Spencer K,. First-trimester placental growth factor as a marker for hypertensive disorders and SGA. Prenat Diagn 2010; 30: 565-570.
8. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH,. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+ 0) to 13(+ 6) weeks of gestation. Prenat Diagn 2008; 28: 1110-1115.
9. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS,. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001; 184: 1267-1272. (Pubitemid 32434285)
10. Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH,. First trimester maternal serum placenta growth factor (PlGF) concentrations in pregnancies with fetal trisomy 21 or trisomy 18. Prenat Diagn 2001; 21: 718-722. (Pubitemid 32929122)
11. Zaragoza E, Akolekar R, Poon LC, Pepes S, Nicolaides KH,. Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies. Ultrasound Obstet Gynecol 2009; 33: 382-386.
12. Debieve F, Moiset A, Thomas K, Pampfer S, Hubinont C,. Vascular endothelial growth factor and placenta growth factor concentrations in Down's syndrome and control pregnancies. Mol Hum Reprod 2001; 7: 765-770. (Pubitemid 32734300)
13. Su YN, Hsu JJ, Lee CN, Cheng WF, Kung CC, Hsieh FJ,. Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome. Prenat Diagn 2002; 22: 8-12. (Pubitemid 34146041)
14. Lambert-Messerlian GM, Canick JA,. Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia. Prenat Diagn 2004; 24: 876-880. (Pubitemid 39576801)
15. Cowans NJ, Stamatopoulou A, Spencer K,. First trimester maternal serum placental growth factor in trisomy 21 pregnancies. Prenat Diagn 2010; 30: 449-453.
16. Kirkegaard I, Petersen OB, Uldbjerg N, Torring N,. Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. Prenat Diagn 2008; 28: 839-844.
17. Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K,. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Ann Clin Biochem 2002; 39: 567-576. (Pubitemid 35316289)
18. Wright D, Spencer K, Kagan KO, Torring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH,. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol 2010; 36: 404-411.
19. Kendall RL, Wang G, Thomas KA,. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996; 226: 324-328. (Pubitemid 26331903)
20. Wa LL, Sahota DS, Wai CL, Chen M, Kin LT, Leung TY,. Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women. J Matern Fetal Neonatal Med 2010; 23: 1475-1480.
21. PerkinElmer Inc. Sample stability of PlGF and PP13 (1244-9934). 1-2-2010. [Accessed 7 November 2010].
22. Cowans NJ, Stamatopoulou A, Hellstrom J, Makela MM, Spencer K,. PAPP-A and free beta-hCG stability in first trimester serum using PerkinElmer AutoDELFIA and DELFIA Xpress systems. Prenat Diagn 2010; 30: 127-132.